Post-stroke Delirium in Ischemic Stroke Patients
Sponsor
Jinan University Guangzhou (Other)
Overall Status
Completed
CT.gov ID
NCT06005636
Collaborator
First Affiliated Hospital of Jinan University (Other)
985
1
19.8
49.7
Study Details
Study Description
Brief Summary
This study is to investigate the predictors of post-stroke delirium, develop and validate a nomogram of post-stroke delirium in the ischemic stroke patients.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
Introduction: Post-stroke delirium (PSD) is associated with unfavorable prognosis. Effectively identifying risk factors of PSD and predicting PSD is of essential.
Methods: This is a prospective, single-centered, cohort study.
Study Design
Study Type:
Observational
Actual Enrollment
:
985 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Risk Factors and Risk Prediction Model for Post-stroke Delirium in Ischemic Stroke Patients
Actual Study Start Date
:
Sep 1, 2021
Actual Primary Completion Date
:
Sep 10, 2022
Actual Study Completion Date
:
Apr 27, 2023
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
with post-stroke delirium ischemic stroke patients with post-stroke delirium |
Diagnostic Test: Test delirium state
use scale to test whether ischemic stroke patients have post-stroke delirium
|
without post-stroke delirium ischemic stroke patients without post-stroke delirium |
Diagnostic Test: Test delirium state
use scale to test whether ischemic stroke patients have post-stroke delirium
|
Outcome Measures
Primary Outcome Measures
- post-stroke delirium [The first week of admission]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 100 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- aged ≥18 years old;(2) ischemic stroke, confirmed by computed tomography (CT) or magnetic resonance imaging (MRI) scans;(3) patients or their agencies agree to participate in this study.
Exclusion Criteria:
- brain dysfunction caused by non-vascular causes such as traumatic brain injury, brain tumor or metastatic brain tumor;(2) history of serious mental illness such as schizophrenia;(3) unable to cooperate to the assessment as deafness, blindness, aphasia, dysarthria;(4) be in coma [Glasgow Coma Scale (GCS)≤8 points] or sedation [Richmond Agitation Sedation Scale (RASS)<-3 points], and do not ameliorate during study;(5) with incomplete data.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | the First Affiliated Hospital of Jinan University | Guangzhou | Guangdong | China | 510630 |
Sponsors and Collaborators
- Jinan University Guangzhou
- First Affiliated Hospital of Jinan University
Investigators
- Principal Investigator: Fengxia Yan, Jinan University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Xiaoyan Cai,
Ms,
Jinan University Guangzhou
ClinicalTrials.gov Identifier:
NCT06005636
Other Study ID Numbers:
- KY-2021-106
First Posted:
Aug 22, 2023
Last Update Posted:
Aug 22, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: